The Bridge program will run through Dec
The analysis quantified the size of the potentially eligible population, characterized prevailing treatment patterns, and assessed early adoption trends during the months following FDA approval of tirzepatide for OSA
En ese sentido, los nuevos frmacos que ya estn disponibles, ms all de su mayor o menor eficacia sobre la prdida de peso, estn demostrando que tienen un efecto directo en otras comorbilidades de la obesidad tan importantes como algunas patologas respiratorias, enfermedad cardiovascular, problemas osteoarticulares, hepticos e incluso algunos tipos de cncer , asegura Mara del Mar Malagn , presidenta de la Sociedad Espaola para el Estudio de la Obesidad (Seedo), en el marco del 32 Congreso Europeo sobre la Obesidad (EASO2025), celebrado esta semana en Mlaga
Rep 75 , 11661176 (2023)
Again, you just wrote a book to try to help primary care physicians think through this, but how prepared are primary care physicians now to have this kind of conversation in which we consider seriously lifestyle and what that can accomplish, but also we don't just either rush to the GLP-1 or say no, you don't need that
&srotate=0)
.png)
